Ole, Ronaldo T.

HRN: 28-96-18  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/06/2026
CEFTRIAXONE 1G (VIAL)
05/06/2026
05/12/2026
IV
2g
OD
Intraabdominal Infection
Checking Initial Appropriateness 
05/07/2026
CEFTRIAXONE 1G (VIAL)
05/07/2026
05/14/2026
IV
2g
Q12
Hepatic Abscess
Checking Initial Appropriateness 
05/07/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/07/2026
05/14/2026
IV
500mg
Q8h
Hepatic Abscess
Checking Initial Appropriateness 
05/07/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/07/2026
05/14/2026
IV
750mg
Q8h
HEPATIC ABSCESS
Checking Initial Appropriateness 
05/07/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/07/2026
05/14/2026
IV
750mg
Q8h
HEPATIC ABSCESS
Checking Initial Appropriateness 
05/11/2026
CIPROFLOXACIN 500MG (TAB)
05/11/2026
05/18/2026
PO
500mg
OD
Hepatomegaly With Abscess Formation Segent VIII
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: